Antiva Biosciences Stock / BioTech & PharmaFounded: 2012

Antiva Biosciences, founded in 2012, is a biopharmaceutical company most well known for their development of small molecule antivirals that improve health outcomes for patients suffering from diseases caused by HPV and other viruses. The company's antivirals are based on a medicinal chemistry platform that focuses on the development and commercialization of direct-acting antivirals for infections with the human papillomavirus, herpes group viruses, HIV and animal retroviruses. Antiva Biosciences is headquartered in South San Francisco, California.

Register To Buy and Sell Shares

For more details on financing and valuation for Antiva Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Antiva Biosciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Antiva Biosciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Kristine M. Ball
President & CEO
Oranee Daniels, MD
Chief Medical Officer
Raju Gadiraju, PhD
Senior Vice President of Pharmaceutical Development and Manufacturing
Sarah Walter, PhD
Senior Vice President of Nonclinical Development & Global Health Strategy
Michael Cordingley, PhD
Senior Virology Adviser

Board Members

Wende S. Hutton
Canaan Partners
Clifford M. Samuel
PCMS1 Consulting
Jenny Yip
Adjuvant Capital
Florencia Segal
MPM-BioImpact Capital
Brian Goodman
MPM-BioImpact Capital

Frequently Asked Questions About Antiva Biosciences’ Stock

Can you buy Antiva Biosciences’ stock?
Antiva Biosciences is not publicly traded on NYSE or NASDAQ in the U.S. To buy Antiva Biosciences’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Antiva Biosciences’ stock?
Yes, you can sell stock of a private company like Antiva Biosciences. Forge can help you sell your Antiva Biosciences stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Antiva Biosciences’ stock price?
Antiva Biosciences is a privately held company and therefore does not have a public stock price. However, you may access Antiva Biosciences’ private market stock price with Forge Data.
What is Antiva Biosciences’ stock ticker symbol?
Antiva Biosciences does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: Jun 16, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.